Your browser doesn't support javascript.
loading
Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation.
Kubal, Chandrashekhar; Mangus, Richard; Fridell, Jonathan; Saxena, Romil; Rush, Natalia; Wingler, Matthew; Ekser, Burcin; Tector, Joseph.
Affiliation
  • Kubal C; 1 Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.2 Department of Pathology, Indiana University School of Medicine, Indianapolis, IN.3 Indiana Donor Network, Indianapolis, IN.
Transplantation ; 100(8): 1699-704, 2016 08.
Article in En | MEDLINE | ID: mdl-27136262
ABSTRACT

BACKGROUND:

Donation after circulatory death (DCD) donor pool remains underutilized for liver transplantation (LT). We describe optimizing "modifiable risk factors," such as cold ischemia time (CIT) recipient warm ischemia time (WIT) and the use of thrombolytic flush at the time of procurement to minimize ischemic cholangiopathy (IC).

METHODS:

From July 2011 (era II), to improve outcomes after DCD LT, measures were taken to minimize CIT, operative time and recipient WIT along with the use of tissue plasminogen activator (tPA) flush during DCD procurements. Thirty consecutive DCD LTs were performed prospectively in era II. Outcomes were compared with 61 historic controls (era I). Reperfusion biopsies were evaluated for the presence of necrosis and biliary epithelial damage.

RESULTS:

Median CIT (4.9 [3.5-5.9] vs 6.4 [4.3-12]; P < 0.001), hepatectomy time (70 [42-120] vs 81 [58-207]; P = 0.02), and recipient WIT (16 [13-31] vs 24[15-40]; P < 0.001) were significantly shorter in era II. All patients in era II received tPA flushed liver grafts. None of the patients in era II developed IC (0% vs 18%; P = 0.013). There were fewer biliary complications in era II, and there was no increased risk of bleeding associated with the use of tPA. One-year graft survival was slightly better in era II (n = 24 patients with 1 year follow-up) (88% vs 80%; P = 0.14).

CONCLUSIONS:

Optimizing peritransplant conditions, such as shortening ischemic times with the use of thrombolytic donor flush, may prevent IC after DCD LT. With this approach, the DCD donor pool may be expanded.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Biliary Tract Diseases / Liver Transplantation / Tissue Plasminogen Activator / Cold Ischemia / Warm Ischemia / Fibrinolytic Agents / Ischemia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2016 Document type: Article Affiliation country: India Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Biliary Tract Diseases / Liver Transplantation / Tissue Plasminogen Activator / Cold Ischemia / Warm Ischemia / Fibrinolytic Agents / Ischemia Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2016 Document type: Article Affiliation country: India Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA